Table 3. Prevalence of HR-HPV infection or CT infections with respect to cervical cytology status.

TBS classification	HR-HPV/N(% of row)			CT/N(% of row)
	Negative	Positive	P Value	Negative	Positive	P Value
NILM	991(94.0%)	63(6.0%)	<0.0001a	801(97.7%)	19(2.3%)	0.055
ASCUS	8(61.5%)	5(38.5%)		10(100.0%)	0(0.0%)
ASC-H	1(25.0%)	3 (75.0%)		2(66.7%)	1(33.3%)
LSIL	2(50.0%)	2(50.0%)		4(100.0%)	0(0.0%)
HSIL	0(0.0%)	2(100.0%)		2(100.0%)	36(0.0%)
AGC	1(100.0%)	0(0.0%)		1(100.0%)	0(0.0%)
Tumor	0(0.0%)	100(100.0%)		1(100.0%)	0 (0.0%)

^a P < 0.0001(Fisher's Exact Test);

HR-HPV: high-risk human papillomavirus; CT: Chlamydia trachomatis; NILM: negative for intraepithelial lesion or malignancy; ASCUS: atypical squamous cells of unknown significance; ASC-H: atypical squamous cells-high grade; LSIL: low-grade squamous intraepithelial neoplasia; HSIL: high-grade squamous intraepithelial lesion; AGC: atypical glandular cells or worse.